Vimarsana
Biggest News Aggregation in the World

Page 39 - Multiple Sclerosis Ms News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Multiple Sclerosis Ms. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Multiple Sclerosis Ms Today - Breaking & Trending Today

Updated MS Guidelines Advocate Earlier, More Aggressive Treatment - Vimarsana News

Updated MS Guidelines Advocate Earlier, More Aggressive Treatment

Updated European guidelines also include a recommendation for siponimod in progressive MS and more detailed information on drug use in pregnancy.

The Barcelona Baseline Risk Score May Predict Long-Term MS Course - Vimarsana News

The Barcelona Baseline Risk Score May Predict Long-Term MS Course

Different prognostic variables come together into a single predictive score.

Ublituximab Improves Functional MS Score: New ULTIMATE Analysis - Vimarsana News

Ublituximab Improves Functional MS Score: New ULTIMATE Analysis

The new anti-CD20 monoclonal antibody showed significant improvement in the multiple sclerosis functional composite (MSFC) score, a measure of disability, compared with teriflunomide.

Care Cues: Improving Joint Decision-Making in Multiple Sclerosis - Vimarsana News

Care Cues: Improving Joint Decision-Making in Multiple Sclerosis

Multiple sclerosis is a complex disease with many treatment options. Experts discuss how to improve communication with patients and facilitate joint decision-making for better disease management.

Rituximab More Effective Than Other MS Treatments? - Vimarsana News

Rituximab More Effective Than Other MS Treatments?

Rituximab reduced relapses and MRI activity more effectively than dimethyl fumarate, natalizumab, and injectable therapies in a recent study. Disability did not differ between treatments, however.